These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21800073)

  • 41. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling.
    Varnum-Finney B; Xu L; Brashem-Stein C; Nourigat C; Flowers D; Bakkour S; Pear WS; Bernstein ID
    Nat Med; 2000 Nov; 6(11):1278-81. PubMed ID: 11062542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal.
    Santaguida M; Schepers K; King B; Sabnis AJ; Forsberg EC; Attema JL; Braun BS; Passegué E
    Cancer Cell; 2009 Apr; 15(4):341-52. PubMed ID: 19345332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.
    Mikesch JH; Steffen B; Berdel WE; Serve H; Müller-Tidow C
    Leukemia; 2007 Aug; 21(8):1638-47. PubMed ID: 17554387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathways involved in the evolution of leukemic stem cells.
    Zhang PY; Yang YJ; Fu CM; Xiang LL; Wang Q; Li XL
    Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1356-63. PubMed ID: 25967709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mouse acute leukemia develops independent of self-renewal and differentiation potentials in hematopoietic stem and progenitor cells.
    Dong F; Bai H; Wang X; Zhang S; Wang Z; Xie M; Zhang S; Wang J; Hao S; Cheng T; Ema H
    Blood Adv; 2019 Feb; 3(3):419-431. PubMed ID: 30733302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identifying leukemia stem cells--is it feasible and does it matter?
    Lutz C; Hoang VT; Buss E; Ho AD
    Cancer Lett; 2013 Sep; 338(1):10-4. PubMed ID: 22820159
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced Hematopoietic Stem Cell Self-Renewal-Promoting Ability of Clonal Primary Mesenchymal Stromal/Stem cells Versus Their Osteogenic Progeny.
    He Q; Scott Swindle C; Wan C; Flynn RJ; Oster RA; Chen D; Zhang F; Shu Y; Klug CA
    Stem Cells; 2017 Feb; 35(2):473-484. PubMed ID: 27539014
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic.
    Laranjeira AB; Yang SX
    Expert Opin Drug Discov; 2016 Nov; 11(11):1071-1080. PubMed ID: 27626707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of Hematopoietic Stem Cell Fate and Malignancy.
    Cho HJ; Lee J; Yoon SR; Lee HG; Jung H
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32640596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
    Lefort S; Maguer-Satta V
    Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hematopoietic stem cell self-renewal.
    Akala OO; Clarke MF
    Curr Opin Genet Dev; 2006 Oct; 16(5):496-501. PubMed ID: 16919448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. S6K1 regulates hematopoietic stem cell self-renewal and leukemia maintenance.
    Ghosh J; Kobayashi M; Ramdas B; Chatterjee A; Ma P; Mali RS; Carlesso N; Liu Y; Plas DR; Chan RJ; Kapur R
    J Clin Invest; 2016 Jul; 126(7):2621-5. PubMed ID: 27294524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relevance of leukemic stem cells in acute myeloid leukemia: heterogeneity and influence on disease monitoring, prognosis and treatment design.
    Wouters R; Cucchi D; Kaspers GJ; Schuurhuis GJ; Cloos J
    Expert Rev Hematol; 2014 Dec; 7(6):791-805. PubMed ID: 25242511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Approaches for targeting self-renewal pathways in cancer stem cells: implications for hematological treatments.
    Horne GA; Copland M
    Expert Opin Drug Discov; 2017 May; 12(5):465-474. PubMed ID: 28277836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The elements of stem cell self-renewal: a genetic perspective.
    Pazianos G; Uqoezwa M; Reya T
    Biotechniques; 2003 Dec; 35(6):1240-7. PubMed ID: 14682059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Wnt and Notch signaling govern self-renewal and differentiation in a subset of human glioblastoma stem cells.
    Rajakulendran N; Rowland KJ; Selvadurai HJ; Ahmadi M; Park NI; Naumenko S; Dolma S; Ward RJ; So M; Lee L; MacLeod G; Pasiliao C; Brandon C; Clarke ID; Cusimano MD; Bernstein M; Batada N; Angers S; Dirks PB
    Genes Dev; 2019 May; 33(9-10):498-510. PubMed ID: 30842215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multilevel targeting of hematopoietic stem cell self-renewal, differentiation and apoptosis for leukemia therapy.
    Tsiftsoglou AS; Bonovolias ID; Tsiftsoglou SA
    Pharmacol Ther; 2009 Jun; 122(3):264-80. PubMed ID: 19306896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance.
    Duncan AW; Rattis FM; DiMascio LN; Congdon KL; Pazianos G; Zhao C; Yoon K; Cook JM; Willert K; Gaiano N; Reya T
    Nat Immunol; 2005 Mar; 6(3):314-22. PubMed ID: 15665828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell signaling pathways as molecular targets to eliminate AML stem cells.
    Rodrigues ACBDC; Costa RGA; Silva SLR; Dias IRSB; Dias RB; Bezerra DP
    Crit Rev Oncol Hematol; 2021 Apr; 160():103277. PubMed ID: 33716201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leukemogenesis via aberrant self-renewal by the MLL/AEP-mediated transcriptional activation system.
    Yokoyama A
    Cancer Sci; 2021 Oct; 112(10):3935-3944. PubMed ID: 34251718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.